Systemically Administered Reovirus-Induced Downregulation of Hypoxia Inducible Factor-1α in Subcutaneous Tumors

Area of Science:

• Oncology
• Virology
• Molecular Biology

Background:

• Reovirus exhibits antitumor properties through tumor-specific replication and other mechanisms.
• Reovirus has been shown to downregulate hypoxia-inducible factor-1α (HIF-1α) in cultured tumor cells.
• The in vivo effect of reovirus on HIF-1α expression in tumors remained unclear.

Purpose of the Study:

• To investigate whether reovirus downregulates HIF-1α and its target genes in tumor-bearing hosts.
• To determine if virus replication is necessary for HIF-1α downregulation in vivo.
• To assess the contribution of tumor cell apoptosis to HIF-1α downregulation.

Main Methods:

• Systemic administration of reovirus to tumor-bearing mice.
• Analysis of HIF-1α protein levels and its target genes in subcutaneous tumors.
• Detection of reovirus capsid protein σ3 in hypoxic tumor regions.
• Administration of UV-inactivated reovirus as a control.
• Assessment of tumor cell apoptosis.

Main Results:

• Reovirus significantly downregulated HIF-1α protein levels and its target genes in tumors 120 hours post-administration.
• Reovirus capsid protein σ3 was detected in hypoxic tumor areas.
• Tumor cell apoptosis was not significantly elevated at the studied time point.
• UV-inactivated reovirus did not cause HIF-1α downregulation, confirming the necessity of viral replication.

Conclusions:

• Reovirus-mediated downregulation of HIF-1α in tumors is dependent on active viral replication.
• Tumor cell killing does not appear to be the primary mechanism for HIF-1α downregulation by reovirus in vivo.
• These findings support the development of reovirus as a virotherapy agent for various cancers.